Abstract:Patients with repaired tetralogy of Fallot remain at risk of life-threatening ventricular tachycardia related to slow-conducting anatomical isthmuses (SCAIs). Preventive ablation of SCAI identified by invasive electroanatomical mapping is increasingly performed. This study aimed to non-invasively identify SCAI using 3D late gadolinium enhancement cardiac magnetic resonance (3D-LGE-CMR). Consecutive tetralogy of Fallot patients who underwent right ventricular electroanatomical mapping (RV-EAM) and 3D-LGE-CMR were included. High signal intensity threshold for abnormal myocardium was determined based on direct comparison of bipolar voltages and signal intensity by co-registration of RV-EAM with 3D-LGE-CMR. The diagnostic performance of 3D-LGE-CMR to non-invasively identify SCAI was determined, validated in a second cohort, and compared with the discriminative ability of proposed risk scores. The derivation cohort consisted of 48 (34 ± 16 years) and the validation cohort of 53 patients (36 ± 18 years). In the derivation cohort, 78 of 107 anatomical isthmuses (AIs) identified by EAM were normal-conducting AI, 22 were SCAI, and 7 blocked AI. High signal intensity threshold was 42% of the maximal signal intensity. The sensitivity and specificity of 3D-LGE-CMR for identifying SCAI or blocked AI were 100% and 90%, respectively. In the validation cohort, 85 of 124 AIs were normal-conducting AI, 36 were SCAI, and 3 blocked AI. The sensitivity and specificity of 3D-LGE-CMR were 95% and 91%, respectively. All risk scores showed an at best modest performance to identify SCAI (area under the curve ≤ .68). 3D late gadolinium enhancement cardiac magnetic resonance can identify SCAI with excellent accuracy and may refine non-invasive risk stratification and patient selection for invasive EAM in tetralogy of Fallot. Consecutive rTOF patients with EAM and 3D-LGE-CMR at two centers were included. In the derivation cohort, 3D-LGE-CMR identified SCAI with excellent sensitivity and specificity, which was confirmed in the validation cohort. The occurrence of spontaneous VT depends on the interplay between a pre-existing substrate, initiating triggers and modulating factors (triangle of arrhythmogenesis). 3D-LGE-CMR can significantly reduce the need for diagnostic EAM procedures. AI, anatomical isthmus; BNP, b-type natriuretic peptide; EAM, electroanatomical mapping; EDV, end-diastolic volume; EF, ejection fraction; HSIt, High signal intensity threshold; LGE-CMR, late gadolinium enhancement cardiac magnetic resonance; PVC, premature ventricular complex; PVO2, peak oxygen uptake; PVR, pulmonary valve replacement; rTOF, repaired tetralogy of Fallot; RVOT, right ventricular outflow tract; RVSP, right ventricular systolic pressure; SCAI, slow conducting anatomical isthmus; SI, signal intensity; VT, ventricular tachycardia.

Non-invasive detection of slow conduction with cardiac magnetic resonance imaging for ventricular tachycardia ablation

Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping

Biophysical Tissue Characterization of Ventricular Tachycardia Substrate With Local Impedance Mapping to Predict Critical Sites

Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study)

Novel systematic processing of cardiac magnetic resonance imaging identifies target regions associated with infarct-related ventricular tachycardia

Detailed Assessment of Low-Voltage Zones Localization by Cardiac MRI in Patients With Implantable Devices

Substrate Mapping for Ventricular Tachycardia Ablation Through High-Density Whole-Chamber Double Extra Stimuli: The S3 Protocol

Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges

Impact of different activation wavefronts on ischemic myocardial scar electrophysiological properties during high-density ventricular tachycardia mapping and ablation

Mapping the Transmural Scar and Activation for Patients with Ventricular Arrhythmia

Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: A dual-center experience

Whole-Heart Histological and Electroanatomic Assessment of Postinfarction Cardiac Magnetic Resonance Imaging Scar and Conducting Channels

Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation

Near-field detection and peak frequency metric for substrate and activation mapping of ventricular tachycardias in two- and three-dimensional circuits

Assessing the ability of substrate mapping techniques to guide ventricular tachycardia ablation using computational modelling

Automated isochronal late activation mapping for substrate characterization in patients with repaired tetralogy of Fallot

Real-time cardiovascular magnetic resonance-guided radiofrequency ablation: A comprehensive review

Detailed analysis of electrogram peak frequency to guide ventricular tachycardia substrate mapping

Imaging to Facilitate Ventricular Tachycardia Ablation: Intracardiac Echocardiography, Computed Tomography, Magnetic Resonance, and Positron Emission Tomography

Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot

MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population